HOME >> MEDICINE >> NEWS
New relief for unexplained chest pain

Iowa City, Iowa May 09, 2007 - The discomfort caused by esophageal (non-cardiac) chest pain is often severe, driving many patients to emergency rooms and physicians' offices despite the fact that the ailment has no definable pathology. Although this pain may sometimes be the result of acid reflux disease, when this is absent most patients present hypersensitivity of the esophagus, and a recent study suggests a potential new way of managing this and other symptoms.

The study finds that theophylline, taken either intravenously or orally, appears to reduce esophageal chest pain by relaxing the esophageal wall and decreasing hypersensitivity. Lead author Satish S.C. Rao finds evidence that these beneficial effects may also be influenced by theophylline's actions on adenosine receptors, altering esophageal sensory thresholds at the same time as relaxing the muscles.

Rao notes that "following oral administration, symptomatic improvement was seen in nearly 60 percent of patients, and the drug was reasonably well tolerated," adding that "if a cardiac, pulmonary, musculoskeletal or esophageal source such as acid reflux disease can be excluded, our findings suggest that a trial of theophylline may be effective in relieving chest pain."


'"/>

Contact: Sean Wagner
swagner@bos.blackwellpublishing.com
781-388-8550
Blackwell Publishing Ltd.
9-May-2007


Page: 1

Related medicine news :

1. New study could bring relief to sweltering city slickers
2. New study demonstrates that Lubiprostone may improve symptom relief rates in adults with IBS-C
3. New treatment offers relief from chronic back pain
4. Stenting of abdominal arteries offers welcome relief for intestinal angina
5. Pain relief effectiveness down to mind-set?
6. Louisiana Tech receives award for hurricane-relief efforts
7. FDA approves prescription Zaditor for over-the-counter relief from itchy eyes
8. Tipsheet: Focus on gait training, pain relief, pressure ulcers and hearing aid training
9. New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots
10. Experimental ragweed therapy offers allergy sufferers longer relief with fewer shots
11. Brief, high-dose steroid treatment offers extended relief to giant cell arteritis patients

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/16/2017)... KS (PRWEB) , ... August 16, 2017 , ... ... latest beneficiary of their recently launched community enrichment program. Partnering once again with ... the KC Superstar competition to help find the area’s very own American Idol. ...
(Date:8/16/2017)... ... August 16, 2017 , ... The Southeastern Telehealth Resource Center ... $975,000, renewing its funding from the Health Resources and Services Administration (HRSA), part ... the fourth time the HRSA administration has renewed its financial support to GPT ...
(Date:8/16/2017)... ... August 16, 2017 , ... LabRoots , the leading provider ... the world, is excited to announce Andrew Ly as the winner of the LabRoots ... textbook costs. , Ly, who is in his third year at the University ...
(Date:8/16/2017)... NEW YORK, NY (PRWEB) , ... August 16, 2017 , ... ... push for better treatments and ultimately, a cure. , The grants are awarded ... is comprised of scientists with a wide array of backgrounds and expertise in all ...
(Date:8/16/2017)... ... August 16, 2017 , ... Melbourne’s reign as the world’s most liveable ... Unit’s (EIU) annual Liveability Index. , The Index surveys 140 of the world’s cities ... 2006, Melbourne has consistently come in the top three of the index. So what ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... CerSci Therapeutics , a non-opioid drug development firm based ... notice from the National Institute on Drug Abuse (NIDA) ... has been awarded a Direct-to-Phase II Small Business Innovation ... an additional $1,000,000 to follow in 2018. These funds ... lead non-opioid drug candidate CT-044 to the Food and ...
(Date:7/31/2017)... 31, 2017 7D Surgical, developer of ground breaking ... the 7D Surgical System to support its strategic sales plan ... and Virginia.  7D Surgical has entered into an ... the premier medical facilities within those markets. ... Spartan ...
(Date:7/27/2017)... WARSAW, Ind., July 27, 2017  Zimmer Biomet Holdings, ... the quarter ended June 30, 2017.  The Company reported ... of 1.1% over the prior year period, and an ... approximately 240 basis points of contribution from the LDR ... from the second quarter of 2016, or 0.3% on ...
Breaking Medicine Technology:
Cached News: